NEW YORK – Chinese infectious disease startup Visions Medical said on Thursday it recently closed a Series B financing round that raised RMB200 million ($28.8 million).
The round was led by CDH Investments with contributions from CICC Capital, the Guangzhou-based firm said. So far, Visions Medical has raised nearly $50 million, including a $14 million Series A round last year.